Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
9.08
+0.12 (1.34%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Nuvectis Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -26.44 | -19 | -22.26 | -19.09 | -12.89 | |
| Stock-Based Compensation | 6.03 | 4.86 | 4.71 | 1.71 | 1.89 | |
| Change in Accounts Payable | 3.78 | -0.27 | -0.14 | 1.85 | 1.59 | |
| Change in Other Net Operating Assets | 0.63 | 2.17 | 1.74 | 1.97 | -0.09 | |
| Operating Cash Flow | -16.01 | -12.25 | -15.95 | -13.56 | -9.5 | |
| Issuance of Common Stock | 31.21 | 12.04 | 16.48 | 31.88 | - | |
| Other Financing Activities | -2.1 | -0.38 | -1.39 | -4.07 | - | |
| Financing Cash Flow | 29.11 | 11.65 | 15.09 | 27.81 | 15.25 | |
| Net Cash Flow | 13.1 | -0.59 | -0.87 | 14.25 | 5.74 | |
| Levered Free Cash Flow | -6.83 | -5.61 | -7.83 | -6.12 | - | |
| Unlevered Free Cash Flow | -6.83 | -5.61 | -7.83 | -6.12 | - | |
| Change in Working Capital | 4.4 | 1.9 | 1.6 | 3.82 | 1.49 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.